Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MILLERKNOLL, INC.MLKN · Entity 4677 | Director | January 15, 2026 | January 16, 2026 |
| Molecular Templates, Inc.MTEM · Entity 85987 | 10% owner | June 13, 2022 | June 21, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MILLERKNOLL, INC.
Report date January 15, 2026 · Filed January 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,479.857 |
Reported balance
After 2026-01-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-15 · Grant · Acquired 6,153 · Balance 30,479.857 F1: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. |
| Common StockSEC Table I · non-derivative | Direct | 33,985.753 |
Reported balance
After 2026-01-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-01-15 · Exercise / conversion · Acquired 3,505.896 · Balance 33,985.753 |
| Common StockSEC Table I · non-derivative | Direct | 39,568.481 |
Reported balance
After 2026-01-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-01-15 · Exercise / conversion · Acquired 5,582.728 · Balance 39,568.481 |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 5,582.7296 |
Reported balance
After 2026-01-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-15 · Exercise / conversion · Disposed 3,505.896 · Balance 5,582.7296 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F3: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 0.0016 |
Reported balance
After 2026-01-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-15 · Exercise / conversion · Disposed 5,582.728 · Balance 0.0016 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F3: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan.
F3: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3.
Molecular Templates, Inc.
Report date June 13, 2022 · Filed June 21, 2022
Jointly reported with SHV Management Services, LLC, Cunningham Joe H, SHV Management Services, LP, SHV Annex Services, LP, Sante Health Ventures I Annex Fund, LP, SANTE HEALTH VENTURES I LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy SHVMS, LLC | 222,000 |
Last balance in matching sequence
After 2022-06-15 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2022-06-13 · Purchase · Acquired 100,000 · Balance 100,000 F1: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Row 2 · 2022-06-14 · Purchase · Acquired 60,000 · Balance 160,000 F1: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Row 3 · 2022-06-15 · Purchase · Acquired 62,000 · Balance 222,000 F1: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Sante Health Ventures I, L.P. | 6,097,298 |
Reported balance
Holding disclosure · report date 2022-06-13 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,097,298 F2: The securities are held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. and may be deemed to be beneficially owned by the SHV Directors, who are managing directors of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Sante Health Ventures I Annex Fund, L.P. | 864,665 |
Reported balance
Holding disclosure · report date 2022-06-13 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 864,665 F2: The securities are held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. and may be deemed to be beneficially owned by the SHV Directors, who are managing directors of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy SHV Management Services, L.P. | 50,000 |
Reported balance
Holding disclosure · report date 2022-06-13 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 50,000 F2: The securities are held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. and may be deemed to be beneficially owned by the SHV Directors, who are managing directors of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2: The securities are held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. and may be deemed to be beneficially owned by the SHV Directors, who are managing directors of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2026 Filed Jan 16, 2026 21:13 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | Exercise / conversionPhantom Stock · Derivative | 5,582.728 | $19.50 | $108,863.20 |
DisclosureSEC source: 0001198064-26-000002 · edgardoc.xml · derivative · entry 5 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0.0016 Underlying: Common Stock · 5,582.728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F3 · derivative.underlying_shares: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:13 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | Exercise / conversionPhantom Stock · Derivative | 3,505.896 | $19.50 | $68,364.97 |
DisclosureSEC source: 0001198064-26-000002 · edgardoc.xml · derivative · entry 4 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,582.7296 Underlying: Common Stock · 3,505.896 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F3 · derivative.underlying_shares: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:13 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | Exercise / conversionCommon Stock | 5,582.728 | $19.50 | $108,863.20 |
DisclosureSEC source: 0001198064-26-000002 · edgardoc.xml · nonDerivative · entry 3 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,568.481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:13 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | Exercise / conversionCommon Stock | 3,505.896 | $19.50 | $68,364.97 |
DisclosureSEC source: 0001198064-26-000002 · edgardoc.xml · nonDerivative · entry 2 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,985.753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:13 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | GrantCommon Stock | 6,153 | $19.50 | $119,983.50 |
DisclosureSEC source: 0001198064-26-000002 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,479.857 F1 · balance_after: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:12 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | GrantCommon Stock | 5,479 | $21.90 | $119,990.10 |
DisclosureSEC source: 0001869938-25-000021 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,461.0915 F1 · balance_after: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 15, 2024 Filed Jan 20, 2024 00:26 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | GrantCommon Stock | 4,515.1158 | $25.47 | $115,000.00 |
DisclosureSEC source: 0001901570-24-000011 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,620.6239 F1 · date: This late filing is due to an inadvertent administrative error and not any error of the reporting person. F2 · balance_after: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 19:10 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | GrantPhantom Stock · Derivative | 5,059 | $22.73 | $114,991.07 |
DisclosureSEC source: 0001901570-23-000014 · edgardoc.xml · derivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,236.0004 Underlying: Common Stock · 5,059 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F2 · balance_after: The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| June 15, 2022 Filed Jun 21, 2022 17:09 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | PurchaseCommon Stock | 62,000 | $0.89 | $55,180.00 |
DisclosureSEC source: 0001209191-22-038470 · doc4.xml · nonDerivative · entry 3 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SHVMS, LLC Disclosed balance after: 222,000 F1 · ownership.nature: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 14, 2022 Filed Jun 21, 2022 17:09 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | PurchaseCommon Stock | 60,000 | $0.87 | $52,200.00 |
DisclosureSEC source: 0001209191-22-038470 · doc4.xml · nonDerivative · entry 2 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SHVMS, LLC Disclosed balance after: 160,000 F1 · ownership.nature: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 13, 2022 Filed Jun 21, 2022 17:09 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | PurchaseCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001209191-22-038470 · doc4.xml · nonDerivative · entry 1 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SHVMS, LLC Disclosed balance after: 100,000 F1 · ownership.nature: The securities are held by SHVMS, LLC ("SHVMS"). Joe Cunningham, M.D. and Douglas D. French (the "SHV Directors") are managing directors of SHVMS and may be deemed to beneficially own the securities held by SHVMS. Each of the SHV Directors disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 15, 2022 Filed Jan 19, 2022 23:27 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | GrantPhantom Stock · Derivative | 3,079 | $37.34 | $114,969.86 |
DisclosureSEC source: 0001901570-22-000024 · edgardoc.xml · derivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,079 Underlying: Common Stock · 3,079 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:36 UTC | MILLERKNOLL, INC. MLKN · Entity 4677 | Exercise / conversionPerformance Shares · Derivative | 3,805 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001238630-22-000004 · edgardoc.xml · derivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1 F1 · derivative.expiration_date: 1 for 1 Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 16:38 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | SaleCommon Stock | 500,000 | $13.05 | $6,525,000.00 |
DisclosureSEC source: 0001209191-20-051158 · doc4.xml · nonDerivative · entry 1 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Sante Health Ventures I, L.P. Disclosed balance after: 6,097,298 F1 · ownership.nature: The securities held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. may be deemed to be beneficially owned by Joe Cunningham, M.D. and Douglas D. French, who are managing directors (the "SHV Directors") of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 22, 2020 16:16 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | SaleCommon Stock | 300,000 | $16.51 | $4,953,000.00 |
DisclosureSEC source: 0001209191-20-031700 · doc4.xml · nonDerivative · entry 1 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Sante Health Ventures I, L.P. Disclosed balance after: 6,597,298 F1 · ownership.nature: The securities held by Sante Health Ventures I, L.P., Sante Health Ventures I Annex Fund, L.P. and SHV Management Services, L.P. may be deemed to be beneficially owned by Joe Cunningham, M.D. and Douglas D. French, who are managing directors (the "SHV Directors") of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document |
| April 30, 2020 Filed May 4, 2020 17:08 UTC | Molecular Templates, Inc. MTEM · Entity 85987 | OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-026853 · doc4.xml · nonDerivative · entry 1 SHV Management Services, LLC · CIK 0001622968 · 10% owner Cunningham Joe H · CIK 0001623014 · 10% owner FRENCH DOUGLAS D · CIK 0001198064 · 10% owner SHV Management Services, LP · CIK 0001622969 · 10% owner Sante Health Ventures I Annex Fund, LP · CIK 0001640842 · 10% owner SHV Annex Services, LP · CIK 0001714737 · 10% owner SANTE HEALTH VENTURES I LP · CIK 0001433076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Sante Health Ventures I, L.P. Disclosed balance after: 6,897,298 F1 · kind: Sante Health Ventures I, LP distributed these shares to its partners on a pro rata basis, for no consideration. F2 · balance_after: SHV Management Services, LP is the general partner of Sante Health Ventures I, L.P., and owns a 5% interest therein. SHV Management Services, LP therefore received 50,000 of the shares distributed by Sante Health Ventures I, L.P and now owns those shares directly. The SHV Directors and SHV Management own those shares indirectly. F3 · ownership.nature: The securities held by Sante Health Ventures I, L.P. and Sante Health Ventures I Annex Fund, L.P. may be deemed to be beneficially owned by Joe Cunningham, M.D. and Douglas D. French, who are managing directors (the "SHV Directors") of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of Sante Health Ventures I, L.P., and SHV Annex Services, LP, which is the general partner of Sante Health Ventures I Annex Fund, L.P. Each of the SHV Directors, SHV Management, SHV Management Services, LP and SHV Annex Services, LP disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:52 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionPerformance Shares · Derivative | 3,800.054 | $33.06 Strike: $0.00 | $125,629.79 |
DisclosureSEC source: 0001238630-19-000021 · edgardoc.xml · derivative · entry 3 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,800.054 shares Expires 1988-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. F3 · balance_after: The Number of Derivative Securities Beneficially Owned Following Reported Transaction reflected in Table II of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:52 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | SaleCommon Stock | 3,800.054 | $33.06 | $125,629.79 |
DisclosureSEC source: 0001238630-19-000021 · edgardoc.xml · nonDerivative · entry 2 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,742.6963 Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:52 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionCommon Stock | 3,800.054 | $0.00 | $0.00 |
DisclosureSEC source: 0001238630-19-000021 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,542.7503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. F2 · balance_after: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 20:18 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | GrantPerformance Shares · Derivative | 3,805 | $33.37 Strike: $0.00 | $126,972.85 |
DisclosureSEC source: 0001238630-19-000010 · edgardoc.xml · derivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 3,805 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. F2 · derivative.expiration_date: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 23:02 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | SaleCommon Stock | 0.95 | $36.45 | $34.63 |
DisclosureSEC source: 0001238630-18-000033 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,465.4854 Read SEC document |
| January 15, 2018 Filed Jan 18, 2018 01:13 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionPerformance Shares · Derivative | 1,016.95 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001238630-18-000021 · edgardoc.xml · derivative · entry 2 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718.298 Underlying: Common Stock · 1,016.95 shares Expires 1988-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. F3 · balance_after: The Number of Derivative Securities Beneficially Owned Following Reported Transaction reflected in Table II of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 15, 2018 Filed Jan 18, 2018 01:13 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionCommon Stock | 1,016.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001238630-18-000021 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,466.4354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. F2 · balance_after: The directly owned common stock holdings reflected in Table I of this form include shares acquired through participation in the Herman Miller Dividend Reinvestment Plan, which satisfies the exemption of Rule 16b-2. Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 21:04 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionPerformance Shares · Derivative | 998 | $30.95 Strike: $0.00 | $30,885.70 |
DisclosureSEC source: 0001238630-17-000020 · edgardoc.xml · derivative · entry 3 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,642.139 Underlying: Common Stock · 998 shares Expires 1988-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Performance shares are equal to phantom stock units that were accrued under the HMI Nonemployee Officer and Director Deferred Compensation Stock Purchase Plan, and are payable in shares of the Company's Common Stock only. Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 21:04 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | SaleCommon Stock | 998 | $30.95 | $30,885.70 |
DisclosureSEC source: 0001238630-17-000020 · edgardoc.xml · nonDerivative · entry 2 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,289.334 Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 21:04 UTC | MILLERKNOLL, INC. MLHR · Entity 4677 | Exercise / conversionCommon Stock | 998 | $0.00 | $0.00 |
DisclosureSEC source: 0001238630-17-000020 · edgardoc.xml · nonDerivative · entry 1 FRENCH DOUGLAS D · CIK 0001198064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,287.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.